John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


Publication year:
All
1 - 10 out of 30Page size: 10
Sort by: Title
  1. Published

    Update on new muscle glycogenosis

    Laforêt, P., Malfatti, E. & Vissing, John, 2017, In: Current Opinion in Neurology. 30, 5, p. 449-456

    Research output: Contribution to journal › Review › Research › peer-review

  2. Published

    Treatment Opportunities in Patients With Metabolic Myopathies

    Ørngreen, M. C. & Vissing, John, 2017, In: Current Treatment Options in Neurology. 19, 11, 16 p., 37.

    Research output: Contribution to journal › Review › Research › peer-review

  3. Published

    The antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind randomized study

    Andersen, G., Hedermann, G., Witting, N., Duno, M., Andersen, H. & Vissing, John, 2017, In: Brain. 140, 9, p. 2295-2305

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Skeletal muscle metabolism during prolonged exercise in Pompe disease

    Preisler, N., Laforêt, P., Madsen, K. L., Husu, E., Vissing, C. R., Hedermann, G., Galbo, Henrik, Lindberg, C. & Vissing, John, Aug 2017, In: Endocrine Connections. 6, 6, p. 384-394 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    Howard, J. F., Utsugisawa, K., Benatar, M., Murai, H., Barohn, R. J., Illa, I., Jacob, S., Vissing, John, Burns, T. M., Kissel, J. T., Muppidi, S., Nowak, R. J., O'Brien, F., Wang, J., Mantegazza, R. & REGAIN Study Group, R. S. G., Dec 2017, In: Lancet Neurology. 16, 12, p. 976-986 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy

    Svenstrup, K., Nielsen, T. T., Aidt, F., Rostgaard, N., Duno, M., Wibrand, F., Vinther-Jensen, T., Law, Ian, Vissing, John, Roos, P., Hjermind, L. E. & Nielsen, Jørgen Erik, Feb 2017, In: The Cerebellum. 16, 1, p. 62-67 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Reply: Dominant LGMD2A: Alternative diagnosis or hidden digenism?

    Vissing, John & Duno, M., 2017, In: Brain. 140, 2, 2 p., e8.

    Research output: Contribution to journal › Comment/debate › Research

  8. Published

    Reliability of the 2- and 6-minute walk tests in neuromuscular diseases

    Knak, K. L., Andersen, L. K., Witting, N. & Vissing, John, 2017, In: Journal of Rehabilitation Medicine. 49, 4, p. 362-366 5 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Pure exercise intolerance and ophthalmoplegia associated with the m.12,294G > A mutation in the MT-TL2 gene: a case report

    Soldath, P., Madsen, K. L., Buch, A. E., Duno, M., Wibrand, F. & Vissing, John, Oct 2017, In: BMC Musculoskeletal Disorders. 18, 6 p., 419.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark

    Witting, N., Werlauff, U., Duno, M. & Vissing, John, Apr 2017, In: Neurology: Genetics. 3, 2, 15 p., e140.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 Next

ID: 915367